Healthcare investment firm Syncona Ltd said on Wednesday Novartis AG will buy its Gyroscope Therapeutics unit for up to $1.5 billion as the Swiss drugmaker seeks access to the British firm's gene ...
Novartis NVS recently announced that will acquire all of the outstanding share capital of the U.K.-based ocular gene therapy company Gyroscope Therapeutics. The acquisition will add GT005 to the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results